# Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-placebo-controlled-dose-ranging-and-pharmacodynamics-study-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Anatole Besarab,Robert Provenzano,Joachim Hertel,Raja I. Zabaneh,Stephen J. Klaus,Tyson Lee,Robert Leong,Stefan Hemmerich,Kin-Hung P. Yu,Thomas B. Neff |
| Citations | 286 |
| DOI | 10.1093/ndt/gfv302 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://academic.oup.com/ndt/article-pdf/30/10/1665/17172631/gfv302.pdf |
| OpenAlex ID | https://openalex.org/W2124116160 |
| PMID | 26238121 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Anatole Besarab](https://scholariq.org/researchers/anatole-besarab/)

## Paper journal

- [Nephrology Dialysis Transplantation](https://scholariq.org/journals/nephrology-dialysis-transplantation/)

## Paper primary topic

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Paper topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.